SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007735
Filing Date
2019-08-08
Accepted
2019-08-08 16:49:13
Documents
52
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20190630x10q.htm 10-Q 1786134
2 EX-31.1 axsm-20190630ex31149f0bc.htm EX-31.1 12065
3 EX-31.2 axsm-20190630ex3123cbd5d.htm EX-31.2 11289
4 EX-32.1 axsm-20190630ex3212a4ee8.htm EX-32.1 5893
5 EX-32.2 axsm-20190630ex32232c6a1.htm EX-32.2 5872
  Complete submission text file 0001558370-19-007735.txt   4881423

Data Files

Seq Description Document Type Size
6 EX-101.INS axsm-20190630.xml EX-101.INS 794204
7 EX-101.SCH axsm-20190630.xsd EX-101.SCH 35671
8 EX-101.CAL axsm-20190630_cal.xml EX-101.CAL 29590
9 EX-101.DEF axsm-20190630_def.xml EX-101.DEF 81852
10 EX-101.LAB axsm-20190630_lab.xml EX-101.LAB 326586
11 EX-101.PRE axsm-20190630_pre.xml EX-101.PRE 225004
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 191010250
SIC: 2834 Pharmaceutical Preparations